$7.78
0.030.39%
At close: -
$7.78
0.000.00%
After Hours: Dec 20, 4:36 PM EDT
Comments
Loading...
Amneal Pharmaceuticals (AMRX) Forecast
NewsEarningsAmneal Pharmaceuticals (AMRX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAmneal Pharmaceuticals (NASDAQ:AMRX) Stock Quotes, Forecast and News Summary
Amneal Pharmaceuticals Stock (NASDAQ: AMRX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Amneal Pharmaceuticals (AMRX) stock?
You can purchase shares of Amneal Pharmaceuticals (NASDAQ:AMRX) through any online brokerage.
Who are Amneal Pharmaceuticals (AMRX) competitors?
Other companies in Amneal Pharmaceuticals’s space includes: WAVE Life Sciences (NASDAQ:WVE), Supernus Pharmaceuticals (NASDAQ:SUPN), Verona Pharma (NASDAQ:VRNA), Tarsus Pharmaceuticals (NASDAQ:TARS) and Neumora Therapeutics (NASDAQ:NMRA).
What is the forecast, or price target, for Amneal Pharmaceuticals (AMRX) stock?
Amneal Pharmaceuticals has a consensus price target of $8.71.
What is the current price for Amneal Pharmaceuticals (AMRX)?
The stock price for Amneal Pharmaceuticals (NASDAQ: AMRX) is $7.78 last updated December 20, 2024 at 4:36 PM EST.
Does Amneal Pharmaceuticals (AMRX) pay a dividend?
There are no upcoming dividends for Amneal Pharmaceuticals.
When is Amneal Pharmaceuticals (NASDAQ:AMRX) reporting earnings?
Amneal Pharmaceuticals’s Q4 earnings are confirmed for Friday, February 28, 2025.
Is Amneal Pharmaceuticals (AMRX) going to split?
There is no upcoming split for Amneal Pharmaceuticals.
What sector and industry does Amneal Pharmaceuticals (AMRX) operate in?
Amneal Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.